Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Change in Inventory: 2022-2025

Historic Change in Inventory for Whitehawk Therapeutics (WHWK) over the last 3 years, with Mar 2025 value amounting to -$170,000.

  • Whitehawk Therapeutics' Change in Inventory rose 65.31% to -$170,000 in Q1 2025 from the same period last year, while for Mar 2025 it was -$796,000, marking a year-over-year decrease of 195.56%. This contributed to the annual value of -$1.1 million for FY2024, which is 134.18% down from last year.
  • As of Q1 2025, Whitehawk Therapeutics' Change in Inventory stood at -$170,000, which was down 7.59% from -$158,000 recorded in Q4 2024.
  • In the past 5 years, Whitehawk Therapeutics' Change in Inventory ranged from a high of $2.2 million in Q4 2023 and a low of -$630,000 during Q3 2024.
  • Its 3-year average for Change in Inventory is $219,889, with a median of -$170,000 in 2025.
  • The largest annual percentage gain for Whitehawk Therapeutics' Change in Inventory in the last 5 years was 861.39% (2023), contrasted with its biggest fall of 4,700.00% (2023).
  • Whitehawk Therapeutics' Change in Inventory (Quarterly) stood at $1.1 million in 2022, then surged by 97.43% to $2.2 million in 2023, then tumbled by 107.10% to -$158,000 in 2024, then surged by 65.31% to -$170,000 in 2025.
  • Its last three reported values are -$170,000 in Q1 2025, -$158,000 for Q4 2024, and -$630,000 during Q3 2024.